

My journey in biomedical science began at UC Berkeley, where I cultivated a fascination with the intricate world of biochemistry. Pursuing my Ph.D. at Stanford University allowed me to delve into cutting-edge research, focusing on the molecular mechanisms underlying genetic disorders.
I started my professional career at the Genome Innovations Research Institute in San Francisco, contributing to our understanding of rare genetic disorders. A move to Boston broadened my experience at Biotech Solutions Corporation, where I played a crucial role in advancing gene therapy research.
Today, as a Principal Investigator at Stanford Medical Center, I am deeply involved in cancer immunotherapy research. My commitment extends beyond the laboratory; I aspire to bridge the gap between scientific discovery and clinical impact, ultimately improving the lives of patients.
Returning to the heart of Silicon Valley, I currently work at CommConnect Telecom as a Principal Investigator. In this capacity, I lead a research group focused on cancer immunotherapy. Our aim is to translate scientific discoveries into clinical applications, bringing innovative treatments to patients.
I embraced a new opportunity in Boston, joining Delta Science Institute as a Senior Research Scientist. My role involved leading a team in the development of novel gene therapies for inherited diseases. I played a key role in project management, experimental design, and data analysis.
My career as a Biomedical Scientist commenced at the Summit Polytechnic Institute of Business. Here, I worked on groundbreaking research projects, investigating the genomic basis of rare genetic disorders. I published several research papers contributing to the understanding of genetic mutations and their clinical significance.